Pharmalittle: We’re reading about FDA rehiring PDUFA staff, pharma and Medicaid prices, and more
The FDA is asking some of its recently fired staff responsible for critically important funding negotiations with drugmakers to return
Related Articles
How to stop the shift of drug discovery from the U.S. to China
U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb explains how to stop the shift.
Pharmalittle: We’re reading about a Trump order to boost U.S. drug making, a key FDA departure, and more
President Trump signed an order designed to lower regulatory hurdles and make it faster for drug companies to manufacture products in the U.S.
Pharmalittle: We’re reading about a Trump order to boost U.S. drug making, a key FDA departure, and more
President Trump signed an order designed to lower regulatory hurdles and make it faster for drug companies to manufacture products in the U.S.
An Overview of Strategies and Therapeutic Advances in Metastatic Prostate Cancer – Rana McKay
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Rana…
Research disrupted at the NIH Clinical Center
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning, I’m back! It seems like
The entire U.S. health care system must be torn down and rebuilt
Americans are far too accepting of political control of health-related decisions when governments have no demonstrated ability to make better decisions than consumers.
How to stop the shift of drug discovery from the U.S. to China
U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb explains how to stop the shift.
Trump policies disrupt trials at NIH Clinical Center, researchers say
The NIH Clinical Center is struggling to carry out its mission of running clinical trials for the hardest-to-treat diseases
20 attorneys general ask federal judge to reverse deep cuts to HHS
Attorneys general in 19 states and Washington, D.C., are challenging HHS cuts, saying the massive restructuring has destroyed lifesaving programs and left states to pick up…
Hospitals and patient groups ramp up opposition to Medicaid cuts as House mulls options
Cuts to the health insurance program are on the table as GOP lawmakers look for ways to pay for President Trump’s tax cuts.